Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Can money grow on trees? Win-win strategies for ’sustainable bioprospecting’

19.04.2005


Experts to debate themes in new book from UN University



UNU-INTECH author Padmashree Gehl Sampath will be available for advance interviews in New York on 18 April. Telephone interviews with European and international media can be arranged on 14-15 April. Please use the contacts listed below or email terrycollins@rogers.com and/or mwangi@intech.unu.edu to schedule a time. A panel presentation and book launch will take place on Tuesday 19 April at the UN Secretariat Building, Conference Room 5, 9:30 - 12:30.

More than a decade after the coming into force of the UN Convention on Biological Diversity (CBD), ’biodiverse’ developing countries are yet to cash-in on their ’green gold’. Most of the innovative bioprospecting partnerships set up in the wake of the CBD, such as the much publicized Merck-INBio collaboration in Costa Rica, and several initiatives coordinated by the International Cooperative Biodiversity Groups (ICBG) Programme, have come to an end without achieving tangible results.


With more pharmaceutical companies turning to exploring other new technologies as sources for new drugs, it is becoming increasingly clear that poor countries might never realize the full benefits of their genetic endowments. An expert panel discussion convened by United Nations University and the International Centre for Trade and Sustainable Development on 19 April 2005, at the UN Headquarters in New York, will debate strategies that developing countries can adopt to attract investments in drug research and development based on genetic resources. Invited panelists include David Newman (US National Institutes of Health); Gordon Cragg (Former Director, Natural Products Drug Research, National Cancer Institute, US); A.H. Zakri, Director, UNU-Institute for Advanced Studies, Japan; Daniel Macgraw, Executive Director, Centre for International Environmental Law, Washington; and Philippe Cullet, Programme Director for Europe, International Environmental Law Research Centre, and Lecturer, SOAS, University of London. Additional speakers will be drawn from Stanford University, Harvard Medical School, and other UN Organizations.

The panel discussion will address the findings of a new book: Regulating Bioprospecting: Institutions for Drug Research, Access and Benefit-Sharing (UNU Press, 2005), authored by Dr. Padmashree Gehl Sampath, a researcher at the Institute for New Technologies (UNU-INTECH) in the Netherlands.

Focusing on the economics of the contracting process, Dr. Gehl Sampath argues that potential investors have been put off by the poor regulatory environment in source countries, and the limitations of international processes governing this process (the most important being the CBD and the Agreement on Trade Related Aspects of Intellectual Property Rights, commonly known as the TRIPS Agreement).

"If biodiverse countries are to attract much-needed drug R&D investments, information on how the drug industry makes use of traditional knowledge and genetic resources, and how the economics of this use- process may affect incentives of parties to use, trade or research on genetic resources, must form an integral part of legal rule-making on bioprospecting", she notes.

The book aims to contribute to this process by defining optimal property rights structures and institutional mechanisms for regulating bioprospecting for drug research in developing countries that can cater simultaneously to issues of fair and equitable distribution of benefits, biodiversity conservation and sustainable development, while promoting optimal R&D into genetic resources. Both the pharmaceutical and botanical sectors are discussed, albeit highlighting the differences between the two with regard to issues of intellectual property protection, traditional medicinal knowledge, and biodiversity conservation.

Dr. Gehl Sampath’s analysis reveals the market imperfections that shape current international trade in valuable genetic resources, and points out the dangers of a simplistic view of bioprospecting as a ’one-shot’ contract between the pharmaceutical firm, the national access authority, and the local and indigenous communities. In reality, the drug R&D process within which both traditional medicinal knowledge and tangible genetic resources play a role is defined by a unique set of economic properties and limitations. The high levels of risk and uncertainty, and huge up-front investments, impose transaction costs on the parties at each stage of the contracting process, which can serve to stall or hinder the bargaining procedures.

"In this context bioprospecting contracts that provide an environment for mutually beneficial exchange with fair distribution of benefits can only be enabled by well-defined property rights propped up by an enabling contractual environment, enforceable in a transparent and accountable regulatory framework".

The key policy recommendations for developing countries focus on how they can:

  • Devise effective policies and institutions to tap the true potential of bioprospecting;
  • Integrate bioprospecting as part of wider health care;
  • Harness bioprospecting collaborations to boost local traditional medicinal knowledge; and
  • Leverage their options in several ongoing international negotiations on access and benefit-sharing.

"Without keeping in mind the complexities of the economic exchange process, the achievement of goals like new medicines, recognition and benefit-sharing for the communities, conservation of biodiversity and positive economic effects for developing countries from genetic resources will remain an elusive goal. Every actor in this process, be it communities, drug firms or governmental authorities from source and user countries has to be aware that high short term profits in an imperfect legal framework is sub- optimal to the long-term collaborative drug R&D option".

Wangu Mwangi | EurekAlert!
Further information:
http://www.ony.unu.edu/
http://www.intech.unu.edu

More articles from Life Sciences:

nachricht Symbiotic bacteria: from hitchhiker to beetle bodyguard
28.04.2017 | Johannes Gutenberg-Universität Mainz

nachricht Nose2Brain – Better Therapy for Multiple Sclerosis
28.04.2017 | Fraunhofer-Institut für Grenzflächen- und Bioverfahrenstechnik IGB

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Making lightweight construction suitable for series production

More and more automobile companies are focusing on body parts made of carbon fiber reinforced plastics (CFRP). However, manufacturing and repair costs must be further reduced in order to make CFRP more economical in use. Together with the Volkswagen AG and five other partners in the project HolQueSt 3D, the Laser Zentrum Hannover e.V. (LZH) has developed laser processes for the automatic trimming, drilling and repair of three-dimensional components.

Automated manufacturing processes are the basis for ultimately establishing the series production of CFRP components. In the project HolQueSt 3D, the LZH has...

Im Focus: Wonder material? Novel nanotube structure strengthens thin films for flexible electronics

Reflecting the structure of composites found in nature and the ancient world, researchers at the University of Illinois at Urbana-Champaign have synthesized thin carbon nanotube (CNT) textiles that exhibit both high electrical conductivity and a level of toughness that is about fifty times higher than copper films, currently used in electronics.

"The structural robustness of thin metal films has significant importance for the reliable operation of smart skin and flexible electronics including...

Im Focus: Deep inside Galaxy M87

The nearby, giant radio galaxy M87 hosts a supermassive black hole (BH) and is well-known for its bright jet dominating the spectrum over ten orders of magnitude in frequency. Due to its proximity, jet prominence, and the large black hole mass, M87 is the best laboratory for investigating the formation, acceleration, and collimation of relativistic jets. A research team led by Silke Britzen from the Max Planck Institute for Radio Astronomy in Bonn, Germany, has found strong indication for turbulent processes connecting the accretion disk and the jet of that galaxy providing insights into the longstanding problem of the origin of astrophysical jets.

Supermassive black holes form some of the most enigmatic phenomena in astrophysics. Their enormous energy output is supposed to be generated by the...

Im Focus: A Quantum Low Pass for Photons

Physicists in Garching observe novel quantum effect that limits the number of emitted photons.

The probability to find a certain number of photons inside a laser pulse usually corresponds to a classical distribution of independent events, the so-called...

Im Focus: Microprocessors based on a layer of just three atoms

Microprocessors based on atomically thin materials hold the promise of the evolution of traditional processors as well as new applications in the field of flexible electronics. Now, a TU Wien research team led by Thomas Müller has made a breakthrough in this field as part of an ongoing research project.

Two-dimensional materials, or 2D materials for short, are extremely versatile, although – or often more precisely because – they are made up of just one or a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Fighting drug resistant tuberculosis – InfectoGnostics meets MYCO-NET² partners in Peru

28.04.2017 | Event News

Expert meeting “Health Business Connect” will connect international medical technology companies

20.04.2017 | Event News

Wenn der Computer das Gehirn austrickst

18.04.2017 | Event News

 
Latest News

Wireless power can drive tiny electronic devices in the GI tract

28.04.2017 | Medical Engineering

Ice cave in Transylvania yields window into region's past

28.04.2017 | Earth Sciences

Nose2Brain – Better Therapy for Multiple Sclerosis

28.04.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>